Breaking News

MDS to Sell Diagnostics Business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MDS, Inc. has signed an agreement to sell its Canadian Diagnostic Services business to Borealis Infrastructure Management, Inc. in a $1.2 billion transaction. This sale is part of the company’s strategic shift to focus on the life sciences market and streamline its cost structure to be more competitive. “The sale of our diagnostics business represents a major milestone for MDS in the transition to a global life sciences company,” said Stephen P. DeFalco, president and chief executive ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters